Sense of Coherence is associated with LDL-cholesterol in patients with type 1 diabetes - The PROLONG-Steno study

Kasper Olesen1,2, Troels Mygind Jensen1,2, Lars Jorge Diaz1

  • 1Steno Diabetes Center A/S, Gentofte, Denmark.

Insights

Sense of Coherence (SOC) is linked to better health outcomes in type 1 diabetes. Higher SOC was associated with lower LDL cholesterol, suggesting it may be protective against metabolic risk factors.

Area of Science:

  • Endocrinology
  • Psychology
  • Public Health

Background:

  • Managing type 1 diabetes (T1D) involves controlling HbA1c, blood pressure, and lipids to prevent complications.
  • Sense of Coherence (SOC) is a psychological construct that may influence health behaviors and outcomes.

Purpose of the Study:

  • To investigate the association between Sense of Coherence (SOC) and clinical risk factors in individuals with type 1 diabetes.
  • To explore the relationship between SOC and biomarkers such as HbA1c, blood pressure, and blood lipids.

Main Methods:

  • Data from 125 long-duration type 1 diabetes patients were collected via questionnaires (including SOC) and linked to electronic health records.
  • Clinical measures included HbA1c, blood pressure, and lipid profiles (LDL-cholesterol, HDL-cholesterol).
  • Statistical analyses, including linear regressions and generalized additive models, were used to examine associations.

Main Results:

  • Medium and high SOC levels were significantly associated with lower LDL-cholesterol (p=0.005) in a non-linear manner.
  • Low SOC was linked to elevated LDL-cholesterol levels.
  • Non-significant trends suggested associations between low SOC and lower HDL-cholesterol and elevated HbA1c.

Conclusions:

  • High Sense of Coherence (SOC) may offer a protective effect against elevated LDL-cholesterol in people with type 1 diabetes.
  • Interventions aimed at enhancing self-management skills in individuals with low SOC could help prevent metabolic risk factor deterioration.
Abstract

Related Concept Videos

Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
656
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.1K
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
590
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.6K